how long have glp-1 been on the market Obesity GLP-1 Market Industry Trends and

Does Medicare Cover Mounjaro (Tirzepatide)

Clinical trials show average weight loss of approximately 13.9% at the 2.4mg weekly dose over 68 weeks

Common side effects include nausea, diarrhea and constipation, which typically subside as the body adjusts to the medication. There are strategies to manage and minimize side effects

For example, if you used to eat three main meals per day, try splitting them up into 68 smaller ones , and see if that offers you some relief

2 GLP-1 RAs, such as semaglutide, also show potential anti-inflammatory properties

Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review